RT Journal
A1 Andersson C, Gislason GH, Torp-Pedersen C
T1 TReatment with clopidogrel after myocardial infarction—reply
JF JAMA
JO JAMA
YR 2012
FD December 19
VO 308
IS 23
SP 2456
OP 2457
DO 10.1001/jama.2012.28741
UL http://dx.doi.org/10.1001/jama.2012.28741
AB 
Lin and colleagues also requested analyses stratified by diabetes duration, presumably because cardiovascular adverse event rates may increase with longer duration of diabetes. As a rough proxy for diabetes duration and severity, we investigated whether a different association with clopidogrel was apparent for those who used insulin compared with those who did not use insulin. We found no evidence of such a differential association.